Regulation #16A-5431: Naloxone Exceptions

Provides expanded access to the overdose-reversing drug, Naloxone, to at risk individuals who are pending discharge or release from correctional facilities, prisons, jails and residential drug treatment facilities.

Regulation Details
IRRC Number 3218 Proposed Regulation Received
Agency Name State Board of Pharmacy PA Bulletin Publish Date
Regulation Status Final-Omitted Close of Public Comment
PA Code 49 Pa. Code Chapter 27 Final Due By
Analysts Assigned Corinne R. Brandt  (CRB)
Fiona E. Cormack  (FEC)
IRRC Comments Due
Final-Omitted Regulation Received October 10, 2018
Public Meeting Date November 15, 2018
Published as Final N/A
Actions Taken
No IRRC Actions taken at this time

  • Proposed Regulation
  • Final Regulation
  • Related Documents
LOADING...

Proposed regulation has not yet been submitted.

Public Comments on Proposed Regulation

There are currently no public comments on the proposed regulation.

 

Legislative Comments (on the Proposed and Final Regulation)

There are currently no legislative comments on the proposed or final regulation.

 

IRRC Comments on Proposed Regulation

There are currently no IRRC comments on the proposed regulation.

 
Public Comments on Final Regulation

There are currently no public comments on the final regulation.

 

Legislative Comments (on the Proposed and Final Regulation)

There are currently no legislative comments on the proposed or final regulation.

 

IRRC Order(s)

There are currently no IRRC orders.

 

In addition to comments, IRRC occasionally receives other correspondence and written materials from state agencies and the legislature regarding pending regulations. These documents can be found on this portion of our website.

There are currently no related documents.